Dallas, TX – May 17, 2016 – Puration, Inc. (PURA) today announced the filing of its quarterly financial report for the period ended March 31, 2016. The Company has recently completed a business plan transition and is preparing to launch a patented cannabis extraction business.
Puration is engaged in a joint venture (JV) agreement with the not-for-profit Nature Comfort Meds to commercialize a patented cannabinoid extraction process developed by Nature Comfort Meds.
Various extracts derived from the patented process have been trialed with positive results in the treatment of illnesses including veterans suffering from PTSD, children with autism, various types of cancer, patients with a variety of neurological disorders, pain management, auto-immune disorders and seizures due to Epilepsy.
The Company recently released details regarding the upcoming launch of an extraction facility in the State of Colorado where the extraction process can be utilized for both the ongoing development of cannabis treatments and at the same time benefit from extracting and selling oil from marijuana into the legal recreational market in Colorado.
As part of its transition into a new business, Puration has recently reestablish good standing with the Depository Trust Company (the “DTC”), lost under previous management, and reestablish its ‘current information’ status with OTC Markets.
Learn more about Puration, Inc. and keep up to date on the rapid changes anticipated throughout 2016 on the Company's website: http://www.purationinc.com/.